Therapeutic Strategies to Enhance the Anticancer Efficacy of Histone Deacetylase Inhibitors

by Claudia P. Miller, Melissa M. Singh, Nilsa Rivera-Del Valle, Christa A. Manton, Joya Chandra
Published 2011-01-01

Three questions for identifying chemically intolerant individuals in clinical and epidemiological populations: The Brief Environmental Exposure and Sensitivity Inventory (BREESI).

by Raymond F Palmer, Carlos R Jaén, Roger B Perales, Rodolfo Rincon, Jacqueline N Forster, Claudia S Miller
Published 2020-01-01

Three questions for identifying chemically intolerant individuals in clinical and epidemiological populations: The Brief Environmental Exposure and Sensitivity Inventory (BREESI)

by Raymond F. Palmer, Carlos R. Jaén, Roger B. Perales, Rodolfo Rincon, Jacqueline N. Forster, Claudia S. Miller, Wen-Jun Tu
Published 2020-01-01

Validation of a Brief Screening Instrument for Chemical Intolerance in a Large U.S. National Sample

by Raymond F. Palmer, Tatjana Walker, David Kattari, Rudy Rincon, Roger B. Perales, Carlos R. Jaén, Carl Grimes, Dana R. Sundblad, Claudia S. Miller
Published 2021-08-01

PCI-24781, a Novel Hydroxamic Acid HDAC Inhibitor, Exerts Cytotoxicity and Histone Alterations via Caspase-8 and FADD in Leukemia Cells

by Nilsa Rivera-Del Valle, Shan Gao, Claudia P. Miller, Joy Fulbright, Carolina Gonzales, Mint Sirisawad, Susanne Steggerda, Jennifer Wheler, Sriram Balasubramanian, Joya Chandra
Published 2010-01-01

Small molecule ErbB inhibitors decrease proliferative signaling and promote apoptosis in philadelphia chromosome-positive acute lymphoblastic leukemia.

by Mary E Irwin, Laura D Nelson, Janice M Santiago-O'Farrill, Phillip D Knouse, Claudia P Miller, Shana L Palla, Doris R Siwak, Gordon B Mills, Zeev Estrov, Shulin Li, Steven M Kornblau, Dennis P Hughes, Joya Chandra
Published 2013-01-01